Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS)

J Epidemiol Community Health. 2012 Oct;66(10):869-73. doi: 10.1136/jech-2011-200314. Epub 2011 Oct 27.

Abstract

Background: Benzodiazepine use is widespread in older people, although its benefit is uncertain.

Aim: To investigate the long-term effect of benzodiazepine use upon dementia risk.

Methods: A prospective cohort of men seen on five occasions over 22 years with full medication histories, repeat measures of cognitive function and a clinical diagnosis of dementia.

Results: Of 1134 men with complete data, 103 (9.1%) had been taking benzodiazepines regularly at one or more phases. These men showed a marked increased incidence of dementia (OR=3.50, 95% CI 1.57 to 7.79, p=0.002), which persisted despite adjustment for psychological distress and other covariates. Men exposed in earlier phases showed a greater association than more recent exposure, counter to what one would expect if this was due to reverse causation, though we failed to demonstrate a dose-response effect with drug duration.

Conclusion: The taking of benzodiazepines is associated with an increased risk of dementia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging / drug effects*
  • Aging / psychology
  • Benzodiazepines / administration & dosage
  • Benzodiazepines / adverse effects*
  • Cognition / drug effects*
  • Confidence Intervals
  • Dementia / chemically induced*
  • Dementia / diagnosis
  • Dementia / epidemiology
  • Follow-Up Studies
  • Humans
  • Incidence
  • Logistic Models
  • Male
  • Middle Aged
  • Odds Ratio
  • Prospective Studies
  • Risk Factors
  • Time Factors
  • Wales / epidemiology

Substances

  • Benzodiazepines